| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.008 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.086 | 0.009 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.01 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.01 |